비교리스트

 카트 문의
시장보고서
상품코드
1655515

세계의 체외식 CO2 제거 기기 시장

Extracorporeal CO2 Removal Devices
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 체외식 CO2 제거 기기 시장은 2030년까지 1억 5,190만 달러에 달할 전망

2024년에 1억 730만 달러로 추정되는 세계의 체외식 CO2 제거 기기 시장은 2030년에는 1억 5,190만 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 6.0%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 체외식 CO2 기계는 CAGR 6.6%를 기록하며, 분석 기간 종료시에는 8,990만 달러에 달할 것으로 예측됩니다. 일회용 분야의 성장률은 분석 기간 중 CAGR 5.4%로 추정됩니다.

미국 시장은 2,940만 달러로 추정, 중국은 CAGR 5.5%로 성장 예측

미국의 체외식 CO2 제거 기기 시장은 2024년에 2,940만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 2,360만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 5.5%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.1%와 5.1%로 예측됩니다. 유럽에서는 독일이 CAGR 4.5%로 성장할 것으로 예측됩니다.

세계의 체외식 CO2 제거 기기 시장 - 주요 동향과 촉진요인 정리

체외 CO2 제거기가 호흡기 관리에 필수적인 이유는?

체외 이산화탄소 제거(ECCO2R) 장비는 기존의 인공호흡에 대한 최소 침습적 대안을 제공함으로써 중증 호흡기 질환 관리에 필수적인 요소로 자리 잡고 있으며, 환자의 혈액에서 이산화탄소(CO2)를 체외로 제거하여 만성폐쇄성폐질환(COPD), 급성호흡곤란증후군(ARDS) 및 기타 이산화탄소 축적이 우려되는 폐질환 환자들에게 도움을 줍니다. (COPD), 급성 호흡곤란 증후군(ARDS) 및 CO2 축적이 심각한 문제가 되는 기타 폐 질환 환자들에게 도움을 줍니다. ECCO2R은 CO2 수준을 낮춤으로써 호흡 기능을 안정화시켜 폐 손상을 유발할 수 있는 고압 인공호흡기를 필요로 하지 않는 중증 환자 관리에 특히 유용하며, 폐의 휴식과 회복을 돕습니다. 또한 휴대가 간편하고 사용하기 쉬운 버전이 개발되어 중환자실 밖에서도 사용이 확대되고 있으며, 만성 호흡기 관리의 유망한 솔루션이 되고 있습니다.

기술 발전은 ECCO2R 시장을 어떻게 형성하고 있는가?

의료 기술의 지속적인 발전으로 ECCO2R 장비는 더욱 효율적이고 컴팩트해져 다양한 환자의 요구에 적응할 수 있게 되었습니다. 이러한 혁신에는 합병증과 감염을 최소화하는 생체적합성 재료의 통합과 각 환자의 특정 상태에 맞는 정확한 CO2 제거를 보장하는 첨단 모니터링 시스템의 사용이 포함됩니다. 의료 분야의 저침습적 접근 방식에 대한 추세는 보다 침습적이지 않은 ECCO2R 장비의 설계로 이어져 보다 빠른 설치와 기존 호흡 보조 시스템과의 통합을 용이하게 하고 있습니다. 또한 각 업체들은 병원과 재택 치료 환경 모두에 유연하게 적용할 수 있는 휴대용 기기 개발에 주력하고 있으며, 만성질환 관리에 새로운 길을 열어가고 있습니다. 이러한 발전으로 ECCO2R 장비는 호흡기 질환 관리에 있으며, 매우 중요한 요소로 자리매김하고 있으며, 의료 비용을 절감하고 환자 예후를 개선하고 있습니다.

ECCO2R 장비의 새로운 응용 및 동향은?

ECCO2R 장비 시장은 그 용도가 기존의 병원 환경을 넘어 확대되고 있습니다. 전 세계에서 만성 호흡기 질환이 증가함에 따라 ECCO2R 장비는 특히 외래 환자 및 재택치료 환경에서 장기 관리 솔루션으로 고려되고 있습니다. 의료진들은 기존의 방법으로는 효과가 없거나 합병증 위험이 있는 중환자 치료 상황에서 ECCO2R 장비의 채택을 늘리고 있습니다. 또한 COVID-19 팬데믹으로 인해 효과적인 호흡 보조 장비의 필요성이 부각되면서 ECCO2R의 효율성과 접근성을 개선하기 위한 연구개발 노력이 더욱 활발해지고 있습니다. 환자의 이동성과 편안함에 대한 관심이 높아지면서 제조업체들은 응급실과 야전병원을 포함한 다양한 치료 환경에서 사용할 수 있는 더 가볍고 다용도한 장비를 생산하기 위해 기술 혁신에 박차를 가하고 있습니다.

ECCO2R 시장의 성장을 가속하는 요인은 무엇인가?

ECCO2R 시장의 성장은 효과적인 CO2 관리 솔루션을 필요로 하는 COPD 및 ARDS와 같은 호흡기 질환의 유병률 증가와 같은 몇 가지 요인에 의해 주도되고 있으며, COVID-19 팬데믹의 영향은 고급 호흡 지원 기술의 필요성을 강조하며 수요를 더욱 자극하고 있습니다. 수요를 더욱 자극하고 있습니다. 또한 생체 적합성 및 최소 침습성 ECCO2R 장비의 개발과 같은 기술 혁신은 다양한 의료 환경에서 이러한 시스템의 채택을 촉진하고 있습니다. 환자의 선호도와 의료비 절감의 필요성에 힘입어 휴대용 및 홈케어용 호흡기 솔루션은 시장 성장을 더욱 가속화하고 있습니다. 특히 신흥 시장에서의 헬스케어 인프라에 대한 투자와 호흡기 장비에 대한 기술 혁신 증가는 ECCO2R 분야에 큰 성장 기회를 가져다 줄 것으로 예상됩니다.

부문

제품(체외 CO2 기계, 일회용, 기타 제품); & 접근(정맥, 동정맥); & 용도(폐이식 교량, 급성호흡곤란증후군(ARDS), 만성폐쇄성폐질환(COPD), 기타 용도); & 최종 용도(병원, 외래수술센터, 클리닉, 기타 최종 용도)

조사 대상 기업의 예(주목 44사)

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR S.P.A
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.03.04

Global Extracorporeal CO2 Removal Devices Market to Reach US$151.9 Million by 2030

The global market for Extracorporeal CO2 Removal Devices estimated at US$107.3 Million in the year 2024, is expected to reach US$151.9 Million by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by the end of the analysis period. Growth in the Disposables segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.4 Million While China is Forecast to Grow at 5.5% CAGR

The Extracorporeal CO2 Removal Devices market in the U.S. is estimated at US$29.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$23.6 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Extracorporeal CO2 Removal Devices Market - Key Trends & Drivers Summarized

Why Are Extracorporeal CO2 Removal Devices Critical for Respiratory Care?

Extracorporeal CO2 removal (ECCO2R) devices have become vital in the management of severe respiratory conditions, offering a less invasive alternative to traditional ventilation. ECCO2R devices function by removing carbon dioxide (CO2) from the patient’s blood externally, providing relief for patients with chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and other lung disorders where CO2 accumulation is a critical concern. These devices are particularly beneficial in managing severe cases without the need for high-pressure mechanical ventilation, which can cause further lung injury. By reducing CO2 levels, ECCO2R devices help stabilize respiratory functions, allowing the lungs to rest and recover. The development of portable and user-friendly versions of these devices is also expanding their use beyond intensive care units, making them a promising solution for chronic respiratory management.

How Are Technological Advancements Shaping the ECCO2R Market?

With continuous advancements in medical technology, ECCO2R devices are becoming more efficient, compact, and adaptable to various patient needs. Innovations include integrating biocompatible materials that minimize complications and infections, and the use of advanced monitoring systems that ensure precise CO2 removal tailored to each patient’s specific condition. The trend toward minimally invasive approaches in healthcare has also led to the design of ECCO2R devices that are less intrusive, enabling quicker setup and easier integration into existing respiratory support systems. Additionally, companies are focusing on developing portable devices that offer greater flexibility for both in-hospital and home care settings, opening new avenues for chronic condition management. These advancements are making ECCO2R devices a pivotal component in the management of respiratory diseases, enhancing patient outcomes while reducing healthcare costs.

What Are the Emerging Applications and Trends in ECCO2R Devices?

The market for ECCO2R devices is expanding as their applications extend beyond traditional hospital settings. With increasing incidences of chronic respiratory diseases globally, these devices are now being explored for long-term management solutions, especially in outpatient and home-care environments. Medical practitioners are increasingly adopting ECCO2R devices for critical care scenarios where traditional methods might be ineffective or pose risks of complications. Furthermore, the COVID-19 pandemic has highlighted the need for effective respiratory support devices, boosting the research and development efforts towards improving ECCO2R efficiency and accessibility. The growing emphasis on patient mobility and comfort is also pushing manufacturers to innovate, producing lighter and more versatile devices that can be used in diverse care settings, including emergency response units and field hospitals.

What Factors Are Fueling the Growth of the ECCO2R Market?

The growth in the ECCO2R market is driven by several factors, including the increasing prevalence of respiratory diseases such as COPD and ARDS, which demand effective CO2 management solutions. The impact of the COVID-19 pandemic has also underscored the necessity for advanced respiratory support technologies, further stimulating demand. Additionally, technological innovations, such as the development of biocompatible and minimally invasive ECCO2R devices, are enhancing the adoption of these systems in various healthcare settings. The push towards portable and home-care respiratory solutions, fueled by patient preference and the need for healthcare cost reduction, is further accelerating the market’s growth. Rising investments in healthcare infrastructure and respiratory device innovation, particularly in emerging markets, are expected to create significant growth opportunities in the ECCO2R sector.

SCOPE OF STUDY:

The report analyzes the Extracorporeal CO2 Removal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Extracorporeal CO2 Machines, Disposables, Other Products); Access (Venovenous, Arteriovenous); Application (Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), Other Applications); End-Use (Hospitals, Ambulatory Surgery Centers, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR S.P.A
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Extracorporeal CO2 Removal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Respiratory Disorders Fueling Demand for CO2 Removal
    • Growing Adoption of Minimally Invasive Respiratory Support Technologies
    • Expansion of Intensive Care Units and Demand for Advanced Respiratory Equipment
    • Increasing Focus on Reducing Ventilator Dependency in Critical Care
    • Technological Advancements in Extracorporeal Life Support Systems
    • Rising Demand for Portable and User-Friendly CO2 Removal Devices
    • Growth in Awareness of Lung Preservation and Respiratory Support Options
    • Increased Research and Development for Efficient Gas Exchange Technologies
    • Growing Investment in Respiratory Care in Hospitals and Clinics
    • Surge in Use of CO2 Removal in Emergency and Acute Care Settings
    • Expansion of Extracorporeal Therapies in Cardiopulmonary Rehabilitation
    • Rising Demand for CO2 Removal in Pediatric and Neonatal Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Extracorporeal CO2 Removal Devices Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Extracorporeal CO2 Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Venovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Arteriovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bridge To Lung Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제